Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002942 · ClinicalTrials.gov registry record · Phase 3
Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer
A Phase 3 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 3
- Development phase
- 136
- Enrollment target
NCT00002942 is a Phase 3 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 136 participants.
The verdict
NCT00002942, a Phase 3 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 136 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with autologous bone marrow transplantation or peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Randomized phase III trial to compare bone marrow transplantation with peripheral stem cell transplantation following carboplatin in treating patients with breast cancer.
Interventions
- PROCEDURE peripheral blood stem cell transplantation
- PROCEDURE autologous bone marrow transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 1996-06 |
| Est. Completion | 2003-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002942
The ClinicalTrials.gov registry entry for NCT00002942 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which peripheral blood stem cell transplantation is the first listed.
NCT00002942 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002942 about?
NCT00002942 is a clinical study titled "Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with autologous bone marrow transplantation or peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill ...
What is the current status of trial NCT00002942?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 136 participants. The study started on 1996-06. Estimated completion is 2003-12.
What interventions are being tested in trial NCT00002942?
The interventions under investigation include: peripheral blood stem cell transplantation (PROCEDURE), autologous bone marrow transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT00002942?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.